Literature DB >> 468991

Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

W Kisiel.   

Abstract

Protein C is a vitamin K-dependent protein, which exists in bovine plasma as a precursor of a serine protease. In this study, protein C was isolated to homogeneity from human plasma by barium citrate adsorption and elution, ammonium sulfate fractionation, DEAE-Sephadex chromatography, dextran sulfate agarose chromatography, and preparative polyacrylamide gel electrophoresis. Human protein C (M(r) = 62,000) contains 23% carbohydrate and is composed of a light chain (M(r) = 21,000) and a heavy chain (M(r) = 41,000) held together by a disulfide bond(s). The light chain has an amino-terminal sequence of Ala-Asn-Ser-Phe-Leu- and the heavy chain has an aminoterminal sequence of Asp-Pro-Glu-Asp-Gln. The residues that are identical to bovine protein C are underlined. Incubation of human protein C with human alpha-thrombin at an enzyme to substrate weight ratio of 1:50 resulted in the formation of activated protein C, an enzyme with serine amidase activity. In the activation reaction, the apparent molecular weight of the heavy chain decreased from 41,000 to 40,000 as determined by gel electrophoresis in the presence of sodium dodecyl sulfate. No apparent change in the molecular weight of the light chain was observed in the activation process. The heavy chain of human activated protein C also contains the active-site serine residue as evidenced by its ability to react with radiolabeled diisopropyl fluorophosphate. Human activated protein C markedly prolongs the kaolin-cephalin clotting time of human plasma, but not that of bovine plasma. The amidolytic and anticoagulant activities of human activated protein C were completely obviated by prior incubation of the enzyme with diisopropyl fluorophosphate. These results indicate that human protein C, like its bovine counterpart, exists in plasma as a zymogen and is converted to a serine protease by limited proteolysis with attendant anticoagulant activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468991      PMCID: PMC372179          DOI: 10.1172/JCI109521

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  The Stuart-Prower factor assay and its clinical significance.

Authors:  F BACHMANN; F DUCKERT; F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-05-01

3.  A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension.

Authors:  P HJORT; S I RAPAPORT; P A OWREN
Journal:  J Lab Clin Med       Date:  1955-07

4.  A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.

Authors:  W N BELL; H G ALTON
Journal:  Nature       Date:  1954-11-06       Impact factor: 49.962

Review 5.  Serine proteases: structure and mechanism of catalysis.

Authors:  J Kraut
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

6.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

7.  Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  M E Nesheim; F G Prendergast; K G Mann
Journal:  Biochemistry       Date:  1979-03-20       Impact factor: 3.162

8.  Bovine protein C: amino acid sequence of the light chain.

Authors:  P Fernlund; J Stenflo; A Tufvesson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

10.  Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma.

Authors:  R G DiScipio; E W Davie
Journal:  Biochemistry       Date:  1979-03-06       Impact factor: 3.162

View more
  66 in total

1.  Production of recombinant protein C in serum-containing and serum-free perfusion culture.

Authors:  T Sugiura; H B Maruyama
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

Review 2.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

3.  Molar absorptivity and A1 cm (1%) values for proteins at selected wavelengths of the ultraviolet and visible regions. XXII.

Authors:  D M Kirschenbaum
Journal:  Appl Biochem Biotechnol       Date:  1982-11       Impact factor: 2.926

4.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  beta-Hydroxyaspartic acid in vitamin K-dependent protein C.

Authors:  T Drakenberg; P Fernlund; P Roepstorff; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

Authors:  D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

7.  Human Protein Z.

Authors:  G J Broze; J P Miletich
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

Authors:  S R Hanson; J H Griffin; L A Harker; A B Kelly; C T Esmon; A Gruber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 10.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.